Can a phone app tame fatty liver? 2,000 patients put to the test
NCT ID NCT07233486
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a digital app that helps doctors guide patients with metabolic fatty liver disease (MAFLD) through diet and exercise plans. Researchers will enroll 2,000 adults aged 18–65 with a BMI of 24–35 and a confirmed MAFLD diagnosis. Participants use the app to track weight and blood sugar, while doctors adjust their lifestyle advice remotely. The goal is to see if this approach leads to meaningful weight loss and better blood sugar control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Digital intelligence software (app-based lifestyle intervention)
- What this could lead to
- If successful, this could provide a scalable, low-cost tool to help people with MAFLD manage their weight and blood sugar, potentially slowing liver disease progression.
- What could go wrong
- This is a non-drug behavioral intervention, so results depend heavily on user adherence. The trial is early-stage and lacks a placebo control, so benefits may be modest or not generalizable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAFLD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hangzhou Normal University Hospital
RECRUITINGHangzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a malaria drug melt liver fat? new trial investigates
- Reishi mushroom tested as fatty liver treatment in new study
- Gut health and gym: new combo tackles fatty liver
- Fatty liver mystery: 1,000 rural bangladeshis to be screened
- Could a daily pill slow kidney failure in fatty liver patients?
- Fatty liver drug hope: semaglutide shows promise in Long-Term study